United Kingdom· GB-APID-42577211000001104
Rezzayo 200mg powder for concentrate for solution for infusion vials
A medicinal product containing rezafungin, registered in United Kingdom by Napp Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Rezafungin
- Manufacturer
- Napp Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin05391520690914
- gtin05012854001213
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Rezafungin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRezzayo 200 mgMundipharma
- SwitzerlandRezzayo 200 mg, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungMundipharma Medical Company, Hamilton, Bermuda, Basel Branch
- CzechiaREZZAYOMundipharma Gesellschaft mit beschränkter Haftung, FRANKFURT
- SpainREZZAYO 200 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONMundipharma Gmbh
- FinlandREZZAYOMundipharma GmbH
- IrelandREZZAYO 200 mg powder for concentrate for solution for infusionMundipharma GmbH
- IcelandRezzayoMundipharma GmbH
- PolandRezzayoMundipharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rezzayo
- Liechtenstein · Rezzayo
- Norway · Rezzayo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/86167865-771d-4bd0-94b1-f5c24e3e9e13 GET /v1/drugs/86167865-771d-4bd0-94b1-f5c24e3e9e13?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42577211000001104",
"desc": "Rezzayo 200mg powder for concentrate for solution for infusion vials (Napp Pharmaceuticals Ltd)",
"form": "Powder for solution for infusion",
"vpid": "42578311000001108",
"source": "dmd",
"vtm_id": "42577811000001103",
"strength": "200 mg",
"substance": "Rezafungin",
"ingredient": "Rezafungin acetate",
"supplier_code": "3592811000001102"
}See everything about rezafungin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.